ArticleScientific reports2025
Enhanced early skin cancer detection through fusion of vision transformer and CNN features using hybrid attention of EViT-Dens169.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Article
- TriDermCancerNet: A hybrid deep learning framework for skin cancer classification.The Journal of international medical research · 2026Article
- Enhanced skin cancer classification for minority classes using Conditional GAN pipeline and CNN-ViT ensemble.Scientific reports · 2026Article
- Transformer-Based Foundation Learning for Robust and Data-Efficient Skin Disease Imaging.Diagnostics (Basel, Switzerland) · 2026Article
- Interpretable lung-constrained RegNetY-ViT framework for pulmonary tuberculosis classification in chest X-rays with radiological feature-guided neuro-symbolic reasoning.Frontiers in medicine · 2026Article
- Multiple Basal Cell Carcinomas in a Long-Term Survivor of Childhood ALL and HSCT-A Call for Dermatologic Vigilance.Life (Basel, Switzerland) · 2025Review
- Artificial Intelligence and New Technologies in Melanoma Diagnosis: A Narrative Review.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Early diagnosis of skin cancer remains a pressing challenge in dermatological and oncological practice. AI-driven learning models have emerged as powerful tools for automating the classification of skin lesions by using dermoscopic images. This study introduces a novel hybrid deep learning model, Enhanced Vision Transformer (EViT) with Dens169, for the accurate classification of dermoscopic skin lesion images. The proposed architecture integrates EViT with DenseNet169 to leverage both global context and fine-grained local features. The EViT Encoder component includes six attention-based encoder blocks empowered by a multihead self-attention (MHSA) mechanism and Layer Normalization, enabling efficient global spatial understanding. To preserve the local spatial continuity lost during patch segmentation, we introduced a Spatial Detail Enhancement Block (SDEB) comprising three parallel convolutional layers, followed by a fusion layer. These layers reconstruct the edge, boundary, and texture details, which are critical for lesion detection. The DenseNet169 backbone, modified to suit dermoscopic data, extracts local features that complement global attention features. The outputs from EViT and DenseNet169 were flattened and fused via element-wise addition, followed by a Multilayer Perceptron (MLP) and a softmax layer for final classification across seven skin lesion categories. The results on the ISIC 2018 dataset demonstrate that the proposed hybrid model achieves superior performance, with an accuracy of 97.1%, a sensitivity of 90.8%, a specificity of 99.29%, and an AUC of 95.17%, outperforming existing state-of-the-art models. The hybrid EViT-Dens169 model provides a robust solution for early skin cancer detection by efficiently fusing the global and local features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.